Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia
Trial ID or NCT#
NCT02856204
Status
NOT RECRUITING
Purpose
This research trial studies the shotgun sequencing of blood samples in diagnosing febrile neutropenia in patients with acute myeloid leukemia. Studying samples of blood from patients with acute myeloid leukemia in the laboratory may help identify pathogens and accurately diagnose infections such as febrile neutropenia.
Official Title
Shotgun Sequencing for Etiologic Diagnosis of Febrile Neutropenia
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Patients with febrile neutropenia - A primary diagnosis of acute myeloid leukemia (AML)
Exclusion Criteria:
- - Prior history of febrile neutropenia
Contact us to find out if this trial is right for you.
Contact
Stanley Deresinski
View on ClinicalTrials.gov
